MRK Merck & Co Inc

Price (delayed)

$80.86

Market cap

$204.25B

P/E Ratio

28.37

Dividend/share

$2.64

EPS

$2.85

Enterprise value

$220.67B

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the ...

Highlights
The P/E is 32% lower than the 5-year quarterly average of 40.7 and 6% lower than the last 4 quarters average of 29.7
Merck's equity has increased by 23% YoY and by 8% from the previous quarter
The net income has declined by 38% year-on-year but it is up by 29% since the previous quarter
The EPS has contracted by 37% YoY but it has grown by 30% from the previous quarter
MRK's gross margin is down by 4.6% year-on-year

Key stats

What are the main financial stats of MRK
Market
Shares outstanding
2.53B
Market cap
$204.25B
Enterprise value
$220.67B
Valuations
Price to earnings (P/E)
28.37
Price to book (P/B)
5.72
Price to sales (P/S)
4.16
EV/EBIT
25.17
EV/EBITDA
18.31
EV/Sales
4.49
Earnings
Revenue
$49.15B
EBIT
$8.77B
EBITDA
$12.05B
Free cash flow
$8.33B
Per share
EPS
$2.85
Free cash flow per share
$3.29
Book value per share
$14.14
Revenue per share
$19.42
TBVPS
$24.2
Balance sheet
Total assets
$93.49B
Total liabilities
$57.63B
Debt
$26.44B
Equity
$35.79B
Working capital
$7.33B
Liquidity
Debt to equity
0.74
Current ratio
1.31
Quick ratio
0.78
Net debt/EBITDA
1.36
Margins
EBITDA margin
24.5%
Gross margin
67.9%
Net margin
14.6%
Operating margin
14.6%
Efficiency
Return on assets
7.9%
Return on equity
23.7%
Return on invested capital
16.1%
Return on capital employed
12.6%
Return on sales
17.8%
Dividend
Dividend yield
3.26%
DPS
$2.64
Payout ratio
92.6%

MRK stock price

How has the Merck stock price performed over time
Intraday
2.17%
1 week
0.14%
1 month
5.6%
1 year
4.92%
YTD
5.51%
QTD
5.51%

Financial performance

How have Merck's revenue and profit performed over time
Revenue
$49.15B
Gross profit
$33.39B
Operating income
$7.2B
Net income
$7.2B
Gross margin
67.9%
Net margin
14.6%
Merck's operating income has soared by 51% from the previous quarter but it has decreased by 36% YoY
MRK's net margin is down by 44% year-on-year but it is up by 23% since the previous quarter
Merck's operating margin has increased by 43% QoQ but it has decreased by 43% YoY
The net income has declined by 38% year-on-year but it is up by 29% since the previous quarter

Growth

What is Merck's growth rate over time

Valuation

What is Merck stock price valuation
P/E
28.37
P/B
5.72
P/S
4.16
EV/EBIT
25.17
EV/EBITDA
18.31
EV/Sales
4.49
The EPS has contracted by 37% YoY but it has grown by 30% from the previous quarter
The P/E is 32% lower than the 5-year quarterly average of 40.7 and 6% lower than the last 4 quarters average of 29.7
Merck's equity has increased by 23% YoY and by 8% from the previous quarter
The price to book (P/B) is 16% lower than the last 4 quarters average of 6.7 and 13% lower than the 5-year quarterly average of 6.4
The revenue has grown by 11% YoY and by 4.7% from the previous quarter
MRK's P/S is 7% below its 5-year quarterly average of 4.4 and 2.9% below its last 4 quarters average of 4.2

Efficiency

How efficient is Merck business performance
Merck's ROE has decreased by 44% YoY but it has increased by 22% from the previous quarter
The ROS has contracted by 41% YoY but it has grown by 22% from the previous quarter
The ROIC fell by 41% YoY but it rose by 28% QoQ
The company's return on assets fell by 40% YoY but it rose by 30% QoQ

Dividends

What is MRK's dividend history
DPS
$2.64
Dividend yield
3.26%
Payout ratio
92.6%
Recent dividends

Financial health

How did Merck financials performed over time
The total assets is 62% more than the total liabilities
Merck's total liabilities has decreased by 4.8% YoY
The total assets has grown by 4.1% YoY and by 3.1% from the previous quarter
MRK's debt is 26% smaller than its equity
The debt to equity has contracted by 24% YoY and by 8% from the previous quarter
Merck's equity has increased by 23% YoY and by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.